However, when using the Prognoscan platform [26]—an extensive collection of publicly available cancer microarray datasets with clinical annotation—we observed that when statistically significant, the higher expression of class I HDAC members is predominantly associated with worse survival. Here, HDAC9 is linked to cancer.